Protocol
FranceCoag operates under a protocol approved by the joint FranceCoag–MHEMO Scientific Committee. The protocol:
- describes the objectives and missions of FranceCoag;
- describes the inherited bleeding disorders eligible for FranceCoag;
- sets out the inclusion criteria and the criteria used to define severity;
- defines the FranceCoag dataset;
- sets out the data collection methods;
- describes how the data are processed;
- provides validated procedures for the whole data life cycle (handling of duplicates, management of objections, etc.).
The protocol is a living document and is updated as needed.